Advice
In the absence of a submission from the holder of the marketing authorisation:
timothy grass pollen allergen (GRAZAX®) is not recommended for use within NHS Scotland.
Indication under review: Disease-modifying treatment of grass pollen induced rhinitis and conjunctivitis in adults and children (5 years or older), with clinically relevant symptoms and diagnosed with a positive skin prick test and/or specific IgE test to grass pollen.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this extension to the indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice39KB (PDF)
Medicine details
- Medicine name:
- timothy grass pollen allergen (GRAZAX)
- SMC ID:
- 868/13
- Indication:
- Disease-modifying treatment of grass pollen induced rhinitis and conjunctivitis in adults and children (5 years or older), with clinically relevant symptoms and diagnosed with a positive skin prick test and/or specific IgE test to grass pollen.
- Pharmaceutical company
- ALK-Abello Ltd
- BNF chapter
- Respiratory system
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 08 April 2013